Abstract
Neural cell adhesion molecule (NCAM) is a membrane protein abundantly expressed in the central nervous system. Recently, it has been reported that dysfunction of NCAM is linked to human brain disorders. Furthermore, NCAM is one of the proteolysis targets of matrix metalloproteinase (MMP), whose activation is implicated in neuronal damage. The aim of this study was to elucidate the involvement of MMP-mediated proteolysis of NCAM in the development of ischemic neuronal damage. Male ddY and MMP-9 knockout (KO) C57BL/6J mice were subjected to 2 h of middle cerebral artery occlusion (MCAO). In MCAO model mice, development of infarction and behavioral abnormality were clearly observed on days 1 and 3 after MCAO. Protein levels of MMP-2 and MMP-9 were significantly increased on days 1 and 3 after MCAO. In addition, full-length NCAM (180 kDa) was significantly decreased, but its metabolite levels increased on day 1 by ischemic stress per se. NCAM small interfering RNA significantly increased the neuronal damage induced by MCAO. MMP inhibition or MMP-9 gene KO attenuated the infarction, behavioral abnormalities, and decrease of NCAM (180 kDa) observed after MCAO in mice. The present findings clearly suggest that MMP-2/MMP-9-mediated NCAM proteolysis is implicated in the exacerbation of ischemic neuronal damage.
Footnotes
This work was supported by grants-in-aid and special coordination funds from the Academic Frontier Project, Cooperative Research Center of Life Sciences.
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
doi:10.1124/jpet.110.178079.
-
ABBREVIATIONS:
- NCAM
- neural cell adhesion molecule
- MMP
- matrix metalloproteinase
- MCAO
- middle cerebral artery occlusion
- CCA
- common carotid artery
- TTC
- 2,3,5-triphenyltetrazolium chloride
- NDS
- neurological deficit score
- ANOVA
- analysis of variance
- WT
- wild type
- KO
- knockout
- siRNA
- small interfering RNA
- DMSO
- dimethyl sulfoxide
- GAPDH
- glyceraldehyde-3-phosphate dehydrogenase
- PBS
- phosphate-buffered saline
- PBS-T
- PBS containing 0.1% Tween 20
- TBS
- Tris-buffered saline
- TBS-T
- TBS containing 0.1% Tween 20
- GM6001
- N-[(2R)-2(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-l-tryptophan methylamide.
- Received December 9, 2010.
- Accepted May 19, 2011.
- Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|